Keyphrases
Hearing Impairment
78%
Older Adults
74%
Confidence Interval
29%
Depressive Symptoms
22%
COVID-19
20%
Pure-tone Average
20%
Atherosclerotic Risk Factors
16%
Intracerebral Hemorrhage
15%
Cochlear Implant
14%
Hearing Aids
14%
Odds Ratio
13%
Cognitive Decline
11%
United States
10%
Hazard Ratio
10%
Physical Functioning
10%
Health ABC
10%
Composition Studies
10%
Body Composition
10%
Health Aging
10%
Cognitive Behavior
9%
Lower Extremity Injury
9%
Physical Therapy
9%
Physical Activity
9%
Retrospective Cohort Study
9%
Remdesivir
9%
Hearing Threshold
8%
Decibel
7%
Incident Disability
7%
Intraventricular Hemorrhage
7%
Physical Function
7%
Functional Outcome
7%
Sectional Analysis
6%
Improved Outcomes
6%
Normal Hearing
6%
Cochlear Implantation
6%
Hypertension
6%
Outcome Prediction
6%
Hospital Admission
6%
Hearing Handicap
6%
Cognitive Health
6%
Aging Health
6%
Elders
6%
Health Assessment
6%
Hearing Level
6%
Evacuation
6%
Age-related Hearing Loss
6%
C-reactive Protein
6%
Absolute Lymphocyte Count
6%
MISTIE
6%
Minimally Invasive Surgery
6%
Nursing and Health Professions
Hearing Impairment
100%
Sensory Aid
32%
Confidence Interval
30%
Cochlea Prosthesis
27%
Pure Tone Audiometry
21%
Atherosclerosis
16%
Loneliness
14%
Odds Ratio
14%
Logopedics
14%
Depression
12%
Disability
11%
Leg Injury
9%
Physiotherapy
9%
Hazard Ratio
8%
Body Composition
8%
Cochlear Implantation
8%
Audiometry
7%
Hearing Care
6%
Injury
6%
Self Report
6%
Diagnosis
6%
Elderly (Age Groups)
6%
Quality of Life
5%
Disease
5%
Severe Acute Respiratory Syndrome
5%
Medicine and Dentistry
Hearing Impairment
25%
Disease
24%
COVID-19
23%
Cerebral Hemorrhage
20%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Apoplexy
11%
Cohort Effect
10%
Evacuation
10%
Minimally Invasive Surgery
10%
Retrospective Cohort Study
10%
Alteplase
10%
Cochlear Implant
9%
Atherosclerosis
9%
Diagnosis
9%
Randomized Controlled Trial
9%
Placebo
9%
Hazard Ratio
8%
Infection
8%
Bleeding
8%
Clinical Trial
6%
Symptom
6%
Health Outcomes
5%
Depression
5%
Odds Ratio
5%
Case-Control Study
5%
Biological Marker
5%
Prevalence
5%
Modified Rankin Scale
5%
Consecutive Case Series
5%
